← Open Payments lookup

DUSTIN DEEMER: Open Payments

NPI 1558549592 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$492 in 17 payments from 11 companies in 2025. Trend: 2023 $1,053 · 2024 $72 · 2025 $492

Food & beverage: $492
CompanyPaymentsAmount
Dexcom, Inc.4$227
Novo Nordisk Inc2$44
PFIZER INC.2$38
Amgen Inc.2$31
Bayer Healthcare Pharmaceuticals Inc.1$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
CeQur Corporation1$23
BETA BIONICS, INC.1$21
Axsome Therapeutics, Inc.1$20
Lilly USA, LLC1$18

Products named: Dexcom G6 Transmitter, ELIQUIS, OTEZLA, Kerendia, CAPLYTA, Rybelsus, CeQur Simplicity, iLet Bionic Pancreas.

Industry payments across TX — which companies pay providers there.